![Albert Hsia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Albert Hsia
Inversor de Capital Privado en iXLife Capital SAS .
Perfil
Albert Hsia is currently a Partner at iXLife Capital SAS since 2011.
Prior to this, he worked as a Director at Mobidiag Oy.
Cargos activos de Albert Hsia
Empresas | Cargo | Inicio |
---|---|---|
iXLife Capital SAS
![]() iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | Inversor de Capital Privado | 01/01/2011 |
Antiguos cargos conocidos de Albert Hsia.
Empresas | Cargo | Fin |
---|---|---|
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Commercial Services |
iXLife Capital SAS
![]() iXLife Capital SAS Investment ManagersFinance Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions. | Finance |
- Bolsa de valores
- Insiders
- Albert Hsia